Estimation of sodiumexcretion should bemade as simple as possible, but not simpler: Misleading papers and editorial on spot urines

Journal of Hypertension

Volumn 33, Issue 4, 2015, Pages 884-886

  He, Feng J ^a   Ivković, Vanja ^b   Jelaković, Bojan ^b   Morris, Joan ^a   MacGregor, Graham A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KBC Zagreb   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; SODIUM; POTASSIUM; SODIUM INTAKE;

BLOOD PRESSURE REGULATION; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; FLUID INTAKE; HEALTH CARE POLICY; HEALTH SERVICE; HIGH RISK POPULATION; HUMAN; LETTER; MATHEMATICAL ANALYSIS; MEDICAL SOCIETY; NON COMMUNICABLE DISEASE; OUTCOME ASSESSMENT; PREHYPERTENSION; PREMATURE MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH; SALT INTAKE; SODIUM EXCRETION; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; TREATMENT INDICATION; URINALYSIS; WORLD HEALTH ORGANIZATION; ADMINISTRATION AND DOSAGE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET; FEMALE; MALE; MORTALITY; PHYSIOLOGY; SODIUM INTAKE; URINE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET; FEMALE; HUMANS; MALE; MORTALITY; POTASSIUM; SODIUM; SODIUM, DIETARY;

EID: 84931571339     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000548     Document Type: Letter

References (20)

1. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590-599.
2. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007; 370:2044-2053.
3. Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 2014; 371:601-611.
4. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371:612-623.
5. Liu K, Cooper R, McKeever J, McKeever P, Byington R, Soltero I, et al. Assessment oftheassociationbetweenhabitual salt intakeandhighblood pressure: methodological problems.Am J Epidemiol 1979; 110:219-226.
6. Ji C, Sykes L, Paul C, Dary O, Legetic B, Campbell NR, et al. Systematic review of studies comparing 24-h and spot urine collections for estimating population salt intake. Rev Panam Salud Publica 2012; 32:307-315.
7. Mente A, O'Donnell MJ, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, et al. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. J Hypertens 2014; 32:1005-1014.
8. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993; 20:7-14.
9. Mente A, O'Donnell MJ, Dagenais G, Wielgosz A, Lear SA, McQueen MJ, et al. Erratum. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. J Hypertens 2014; 32:1915.
10. McLean R, Williams S, Mann J. Monitoring population sodium intake using spot urine samples: validation in a New Zealand population. J Hum Hypertens 2014; 28:657-662.
11. Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation 2012; 126:2880-2889.
12. Cobb LK, Elliott AC, Hu P, Liu FB, Neaton K, Whelton JD, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a Science Advisory From the American Heart Association. Circulation 2014; 129:1173-1186.
13. Oparil S. Low sodium intake: cardiovascular health benefit or risk? N Engl J Med 2014; 371:677-679.
14. He FJ, MacGregor GA. Reducing population salt intake worldwide: from evidence to implementation. Prog Cardiovasc Dis 2010; 52:363-382.
15. He FJ, Brinsden HC, MacGregor GA. Salt reduction in the United Kingdom: a successful experiment in public health. J Hum Hypertens 2014; 28:345-352.
16. He FJ, Pombo-Rodrigues S, MacGregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open 2014; 4:e004549.
17. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis 2006; 49:59-75.
18. First Global Ministerial Conference on Healthy Lifestyles and Noncommunicable Disease Control, 28-29 April 2011, Moscow. http:// www.who.int/nmh/events/moscow-ncds-2011/en/. [Accessed 10 June 2013]
19. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the noncommunicable disease crisis. Lancet 2011; 377:1438-1447.
20. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014; 371:624-634.